Company: PACB
Filing Date: 2025-03-17
Form Type: 10-K
Source: 0001299130-25-000061
Chunk: 874

Company: PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Filing Date: 2025-03-17
Form: 10-K
Item: Item 3
Chunk 874
---
ortization of intangible assets27,412 8,261 913 Amortization of right-of-use assets12,165 6,810 6,925 Share-based compensation expense71,036 72,118 78,613 Impairment charges184,500 — — Merger-related compensation expense— 3,395 — Loss on extinguishment of debt— 2,033 — Gain on debt restructuring(154,407)— — Accretion of discount and amortization of premium on marketable securities, net(13,044)(12,840)(244)Change in the estimated fair value of contingent consideration(850)15,060 2,377 Inventory provision4,618 10,584 6,027 Deferred income taxes(205)(11,424)— Other(628)1,059 918 Changes in assets and liabilities Accounts receivable, net9,091 (17,829)5,455 Inventory, net(8,320)(13,841)(33,906)Prepaid expenses and other assets 2,228 (8,984)(12,324)Accounts payable 1,405 206 1,025 Accrued expenses (26,342)13,103 (3,651)Deferred revenue (2,108)(10,420)(3,734)Operating lease liabilities(11,920)(8,759)(7,724)Contingent consideration liability— (14,882)— Other liabilities (4,612)2,449 887 Net cash used in operating activities (206,058)(259,173)(263,211)Cash flows from investing activitiesPurchase of property and equipment (6,188)(8,843)(16,750)Purchase of intangible assets— — (179)Cash paid for purchases of acquired entities, net of cash acquired— (102)— Purchase of investments (498,635)(756,567)(442,788)Sales of investments 34,856 595 — Maturities of investments 593,971 769,521 575,800 Net cash provided by investing activities 124,004 4,604 116,083 Cash flows from financing activitiesProceeds from issuance of common stock under equity offerings, net of issuance costs— 189,200 — Proceeds from issuance of common stock from equity plans7,703 15